Biologic Adjuncts in Hand Surgery: Current Evidence, Limitations, and Clinical Implications

Authors

• Joseph Kelly, Thomas Jefferson UniversityFollow

Abstract

Introduction Biologic therapies such as platelet-rich plasma (PRP) and mesenchymal stem cell (MSC) based treatments, have gained substantial attention across orthopaedics as agents that may enhance tissue healing and modulate inflammation.^1,4 Their use has expanded in the management of degenerative joint disease, tendinopathies, and fracture nonunion across multiple subspecialties within the field.^1,3,6 Despite the developing research base, prior hand-focused reviews have noted that orthobiologics in hand surgery remains an underdeveloped area, leaving limited guidance available to inform clinical decision making.^1-2

Recommended Citation

Kelly, Joseph (2026) "Biologic Adjuncts in Hand Surgery: Current Evidence, Limitations, and Clinical Implications," Bone Bulletin: Vol. 4: Iss. 1, Article 13.
Available at: https://jdc.jefferson.edu/bone_bulletin/vol4/iss1/13